A challenge paradigm was designed to test the functional sensitivity to anticholinergic agents in Alzheimer's disease. Ten patients with dementia of the Alzheimer type were serially administered three different intravenous doses of the centrally active anticholinergic drug scopolamine and placebo. T
✦ LIBER ✦
Alzheimer’s disease: a challenge for modern neuropathobiology
✍ Scribed by Kurt A. Jellinger
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 92 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Scopolamine challenges in Alzheimer's di
✍
Trey Sunderland; Pierre Tariot; Dennis L. Murphy; Herbert Weingartner; Edward A.
📂
Article
📅
1985
🏛
Springer
🌐
English
⚖ 319 KB
Alzheimer's disease genetics: current kn
✍
Paul Hollingworth; Denise Harold; Lesley Jones; Michael J. Owen; Julie Williams
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 161 KB
👁 1 views
## Abstract Alzheimer's disease (AD) is highly heritable, but genetically complex. Recently, three large‐scale genome‐wide association studies have made substantial breakthroughs in disentangling the genetic architecture of the disease. These studies combined include data from over 43 000 independe
Treatment for Alzheimer's disease
✍
Gordon K Wilcock
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 46 KB
👁 1 views
Immunization for Alzheimer's disease
✍
Einar M. Sigurdsson; Blas Frangione; Thomas Wisniewski
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 96 KB
Increased CSF HVA response to arecoline
✍
N. Pomara; M. Stanley; P. A. LeWitt; M. Galloway; R. Singh; D. Deptula
📂
Article
📅
1992
🏛
Springer
🌐
English
⚖ 920 KB
Fibromyalgia: a challenge for modern med
✍
B. Van Houdenhove
📂
Article
📅
2003
🏛
Springer
🌐
English
⚖ 70 KB